Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to improve fire safety in healthcare settings.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The National Health Service has unique fire safety issues given the nature of its services and the patients it treats. These issues and related risks are analysed with risk reduction measures such as specific technical guidance updates and technical bulletins based on this data being developed and published where appropriate. Professional networking ensures that best practice is shared with the NHS via professional organisations such as National Fire Chiefs Council, the National Association of Healthcare Fire Officers, and the Institute of Healthcare Engineering and Estate Management.
This specific fire safety guidance is provided to the NHS in the Health Technical Memorandum 05 generally referred to as Firecode. This guidance is being revised to fully reflect recent changes in legislation, technology, and policy, and is available at the following link:
https://www.england.nhs.uk/publication/fire-safety-in-the-nhs-health-technical-memorandum-05-03/
Asked by: Alex Brewer (Liberal Democrat - North East Hampshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of retail sold magnets on the safety of cerebrospinal fluid shunts programmable externally by magnets.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring that medicines, medical devices, and blood components for transfusions on the market in the United Kingdom are safe, effective, and manufactured to the highest standards of quality. The Medical Devices Regulations 2002 (MDR 2002) establish the statutory framework that medical devices must meet in order to comply with these standards.
All medical devices, including cerebrospinal fluid shunts programmable externally by magnets, must comply with the MDR 2002, which include bearing the UKCA or CE marking on the packaging or labelling of the device. Manufacturers or their UK representatives must monitor use of these devices when used in the UK. The manufacturer holds the legal responsibility for obtaining the necessary certification and registering their medical devices with the MHRA, the UK Competent Authority. Higher risk medical devices are assessed and approved by Approved Bodies in the UK or Notified Bodies in the European Union.
As part of meeting the requirements of the regulations, manufacturers have to provide instructions which would include any special operating instructions, any warnings and/or precautions to take, and precautions to be taken as regards exposure, in reasonably foreseeable environmental conditions, to magnetic fields. In addition, some manufacturers provide further standalone information on this topic, an example of which is available at the following link:
Asked by: Aphra Brandreth (Conservative - Chester South and Eddisbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what actions he is taking to reduce the length of time older people spend on trolleys in Accident and Emergency departments, including cases where patients wait many hours or days; and what assessment he has made of the impact of such waits on dignity, safety and health outcomes.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Government recognises that urgent and emergency care performance has fallen short in recent years and is taking action to improve services for patients. We are committed to restoring accident and emergency waiting times to the National Health Service constitutional standard and to reducing long waits that can result in patients receiving care in inappropriate settings. To support this, we are investing £450 million to expand same-day and urgent care services and to improve hospital flow, with a focus on addressing the longest waits and improving patient experience.
As committed to in the Urgent and Emergency Care plan, we will publish data on the prevalence of corridor care for the first time. NHS England has been working with trusts since 2024 to put in place, new reporting arrangements to drive improvement. The data quality is currently being reviewed, and we expect to publish the information shortly.
Where corridor care cannot be avoided, we have published updated guidance to support trusts to deliver it safely, ensuring dignity and privacy is maintained to reduce impacts on patients and staff.
Our Urgent and Emergency Care Plan for 2025/26 sets out clear actions to deliver improvements, reducing the proportion of patients waiting more than 12 hours for admission or discharge to less than 10% of the time. This includes expanding urgent community care, such as urgent community response, neighbourhood multidisciplinary teams, and virtual wards, to reduce avoidable emergency department attendances and hospital admissions. We have asked NHS trusts to focus on eliminating discharge delays of more than 48 hours caused by issues within the hospital, and to work with local authorities on eliminating the longest delays. The NHS Medium-Term Planning Framework sets out a year-on-year trajectory to improve performance towards the constitutional standard, reduce long waits, and improve safety and efficiency in emergency departments.
We have also introduced new clinical operational standards for the first 72 hours of care to support better hospital flow. These set minimum expectations for timely review, availability of advice, and coordinated care when multiple specialist teams are involved, to improve patient care and flow through the hospital.
Asked by: Stuart Anderson (Conservative - South Shropshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to help restrict the sale of illegal prescription drugs online.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for the regulation of medicines for human use, medical devices, and blood products for transfusion in the United Kingdom. This includes applying the legal controls on the retail sale, supply, and advertising of medicines which are set out in the Human Medicines Regulations 2012.
Sourcing medicines from unregulated suppliers significantly increases the risk of getting a product which is either falsified or not authorised for use. Products purchased in this way will not meet the MHRA’s strict quality and safety standards and could expose patients to incorrect dosages or dangerous ingredients. The MHRA’s Criminal Enforcement Unit works hard to prevent, detect, and investigate illegal activity involving medicines and medical devices. It works closely with other health regulators, customs authorities, law enforcement agencies, and private sector partners, including e-commerce and the internet industry to identify, remove, and block online content promoting the illegal sale of medicines and medical devices.
The MHRA seeks to identify and, where appropriate, prosecute online sellers responsible for putting public health at risk. In 2025, the MHRA and its partners seized almost 20 million doses of illegally traded medicines with a street value of nearly £45 million.
During the same period, it disrupted over 1,500 websites and posts on social media accounts selling medicinal products illegally. Additionally, collaboration with one well-known online marketplace led to the successful identification and blocking of more than two million unregulated prescription medicines, over-the-counter medicines, and medical devices before they could be offered for sale to the public.
The MHRA is continually developing new and innovative ways to combat the illegal trade in medicines and to raise public awareness. These measures include:
- publication of a #Fakemeds campaign which explains how to access medicines through safe and legitimate online sources, with further information available at the following link:
https://fakemeds.campaign.gov.uk/;
- public guidance on how to safely access and use GLP-1 medications, available at the following link:
https://www.gov.uk/government/publications/glp-1-medicines-for-weight-loss-and-diabetes-what-you-need-to-know/glp-1-medicines-for-weight-loss-and-diabetes-what-you-need-to-know.
- implementation of a web-based reporting scheme allowing users to report suspicious online sellers to the MHRA;
- rollout of an online service which will allow users to check if a website has been deemed ‘Not Recommended’ by the MHRA; and
- extensive work with media outlets to raise awareness of the dangers of illegal medicines.
Asked by: Aphra Brandreth (Conservative - Chester South and Eddisbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that older patients are not discharged from hospital prematurely due to bed pressures; and what measures are in place to safeguard patient safety during the discharge process.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to ensuring that all patients are discharged from hospital appropriately with the right care and support in place. Clinicians in every speciality use a set of criteria and clinical judgement to determine when a patient is medically fit for discharge, and where people need further care after discharge, multi-disciplinary care transfer hubs bring together the National Health Service, local authorities, social care, housing, and other professionals to make arrangements for safe and timely discharge.
Asked by: Claire Young (Liberal Democrat - Thornbury and Yate)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of providing compensation to patients treated with rectopexy mesh for rectal prolapse as part of its work on redress following the recommendations of the Hughes Report, published on 7 February 2024.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
As set out in the Hughes Report, the Government is carefully considering the Patient Safety Commissioner’s (PSC’s) recommendations, including the proposed approaches to redress for those harmed by pelvic mesh. The Hughes Report did not cover patients treated with rectopexy mesh for rectal prolapse. This is because rectal prolapse does not fall within the original definition of Pelvic Organ Prolapse that the PSC and the Independent Medicines and Medical Devices Safety Review adopted, namely a pelvic organ bulging into the vagina.
However, that is not to dismiss the very real concerns of these patients. We are considering whether rectopexy mesh should be included in the scope of the work on redress, as for example, NHS England has carried out a market engagement event to understand which of its currently commissioned mesh centres would be willing to provide mesh removal surgery for colorectal patients. A decision around which centres will be designated will be made following findings from the audit of existing mesh centres.
This is a complex, cross-Government policy area involving multiple organisations. This work requires coordinated input from several departments, and we will provide a further update in due course. I met with the PSC in December 2025, to discuss progress following the Hughes Report. I have subsequently written to Dr Hughes about the actions we are undertaking to ensure service-level interventions are embedded in the National Health Service specific to making a real-life impact on those affected by pelvic mesh and valproate.
Asked by: Baroness Bennett of Manor Castle (Green Party - Life peer)
Question to the Foreign, Commonwealth & Development Office:
To ask His Majesty's Government how many people have come to the UK under the Gaza medical evacuation scheme (1) in the past month and (2) overall, either at public expense or through private funding.
Answered by Baroness Chapman of Darlington - Minister of State (Development)
We have supported 50 sick and injured children to leave Gaza and receive treatment in the UK, and have separately supported an initiative by Project Pure Hope to bring several children from Gaza to the UK for privately funded specialist care. The safety, privacy, and wellbeing of these patients and their families remains our absolute priority and we will not be providing further operational details.
We continue to seek the most effective ways to deploy the UK's resources to meet healthcare needs in Gaza and the region. Further announcements on the future of this scheme will be made in the usual way in due course.
Asked by: Baroness Bennett of Manor Castle (Green Party - Life peer)
Question to the Foreign, Commonwealth & Development Office:
To ask His Majesty's Government what steps they are taking to facilitate further evacuations under the Gaza medical evacuation scheme, either at public expense or through private funding; what assessment they have made of obstacles to such evacuations; and what steps they are taking to remove any obstacles.
Answered by Baroness Chapman of Darlington - Minister of State (Development)
We have supported 50 sick and injured children to leave Gaza and receive treatment in the UK, and have separately supported an initiative by Project Pure Hope to bring several children from Gaza to the UK for privately funded specialist care. The safety, privacy, and wellbeing of these patients and their families remains our absolute priority and we will not be providing further operational details.
We continue to seek the most effective ways to deploy the UK's resources to meet healthcare needs in Gaza and the region. Further announcements on the future of this scheme will be made in the usual way in due course.
Asked by: Steve Darling (Liberal Democrat - Torbay)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of sexual misconduct policies implemented by NHS integrated care boards for protecting NHS staff from sexual misconduct by other staff members.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Sexual misconduct of any kind has no place in the National Health Service. NHS England is actively working to ensure that the NHS is a safe environment for employees, patients, and visitors.
NHS England published the Sexual Safety Charter in 2023, setting out the principles we expect all NHS organisations to uphold. Every integrated care board (ICB) and NHS trust has now signed up to the charter and are in the process of assuring themselves that actions are being taken against all principles. Further information on the Sexual Safety Charter is available at the following link:
https://www.england.nhs.uk/long-read/sexual-safety-in-healthcare-organisational-charter/
In 2024, all ICBs and NHS trusts were asked to implement the Sexual Misconduct Policy Framework which proposes that NHS organisations adopt, among other things, anonymous reporting mechanisms for staff. In line with this policy, approximately three quarters of all trusts have adopted anonymous reporting of sexual misconduct allegations. Further information on the Sexual Misconduct Policy Framework is available at the following link:
https://www.england.nhs.uk/publication/national-people-sexual-misconduct-policy-framework/
From August 2025, all trusts and ICBs were required to audit their sexual misconduct policies, review and update relevant policies, such as information sharing and chaperoning, and keep Electronic Staff Records up to date with ongoing and completed staff investigations.
In December 2025, all trusts and ICBs were required to redouble their efforts in relation to sexual misconduct. This includes participating in nationally commissioned training on investigating sexual misconduct cases, ensuring they have a pool of specially trained doctors and dentists, and implementing review groups for cases where there is a sexual dimension to allegations. A further requirement on ICBs and trusts to audit their sexual misconduct policies was issued at this time
The Government will introduce a new set of standards for modern employment in April 2026. The new standards are likely to focus on areas such as improving staff health and wellbeing and dealing with violence, racism, and sexual harassment in the NHS workplace. They will provide a framework for leaders across the NHS to build a supportive culture.
While important progress is being made on sexual misconduct policies, the Government is clear that we will continue to monitor and take all necessary action to address sexual misconduct in the NHS.
Asked by: Alison Bennett (Liberal Democrat - Mid Sussex)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many patients are being treated in temporary hospital environments, including corridors, for which the latest data is available.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
We recognise that the provision of clinical care in corridors or other non-designated clinical areas is unacceptable and are committed to eradicating it from our National Health Service.
Our Urgent and Emergency Care Plan, published in June 2025, set out steps we are taking to ensure that patients will receive better, faster, and more appropriate emergency care this winter, backed by a total of nearly £450 million of funding. This includes a commitment to publish data on the prevalence of corridor care.
NHS England has been working with trusts to put in place new reporting arrangements regarding the use of corridor care to drive improvement and data transparency. The data quality is currently being reviewed, and we expect to publish the information shortly.
We are also introducing new clinical operational standards for the first 72 hours of care, setting clear expectations for timely reviews and specialist input, further supporting our efforts to eliminate corridor care and improve patient experience.
In December, NHS England published updated guidance on providing care in corridors to support trusts with making decisions on corridor care transparently, with clear governance and oversight to reduce impacts on patients and staff and to ensure the safety and dignity of patients.